GRAIL, Inc. Announces $325.0 Million Private Placement Financing
Provided By PR Newswire
Last update: Oct 20, 2025
MENLO PARK, Calif., Oct. 20, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that it has entered into a securities purchase agreement for a private placement that is expected to result in gross proceeds of approximately $325.0 million, before deducting placement agents' fees and other expenses.
Read more at prnewswire.com
